FindTrial
Sign In

Minimum alveolar concentration of sevoflurane with a rapid intravenous administration of dexmedetomidine for deep extubation in children

Minimum alveolar concentration of sevoflurane with a rapid intravenous administration of dexmedetomidine for deep extubation in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070329
Enrollment
Unknown
Registered
2023-04-10
Start date
2023-04-10
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obstructive sleep apnea syndrome

Interventions

one:rapid intravenous administration of dexmedetomidine

Sponsors

Children’s Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 10 Years

Inclusion criteria

Inclusion criteria: Children 3–10 years old with American Society of Anesthesiologists Classification (ASA) I–II undergoing elective Adenotonsillectomy

Exclusion criteria

Exclusion criteria: Children with craniofacial malformations, cognitive dysfunction, obesity (BMI>95th percentile for age), gastroesophageal reflux disease or difficult airway were excluded

Design outcomes

Primary

MeasureTime frame
sevoflurane concentration;—

Secondary

MeasureTime frame
Anesthesia time;Surgical time;Extubation time;Respiratory adverse events;—

Countries

China

Contacts

Public ContactGuo Jian

Children’s Hospital of Fudan University

744734170@qq.com+86 151 2112 1815

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026